<DOC>
	<DOCNO>NCT03063697</DOCNO>
	<brief_summary>The purpose study Evaluate Safety DILATREND SR Cap . Korean Patients Essential hypertension , Chronic stable angina Congestive heart failure 52 week .</brief_summary>
	<brief_title>Observational Study Evaluate Safety DILATREND SR Cap . Korean Patients With Essential Hypertension , Chronic Stable Angina Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>1 . Age 19 year old Patients Essential hypertension , Chronic stable angina Congestive heart failure 2 . Possible take Dilatrend SR label 3. take Caverdilol 6 month Agreement date 4 . Agreement write informed consent 1 . Pregnancy lactation 2 . Known hypersensitivity Carvedilol 3 . Cardiogenic shock 4 . Abnormality conduction system Severe bradycardia ( In particular , pulse &lt; 50beats / min ) , 2nd degree AV block , Complete AV block , Sinus Block , Sick Sinus Syndrome 5 . Cor pulmonale 6 . IDDM ketoacidosis , metabolic acidosis 7. severe heart disease ( Heart failure NYHA functional class 4 ) 8 . Respiratory disease Asthma , Chronic Obstructive Pulmonary Disease 9 . Secondary hypertension 10 . Prinzmetal 's angina 11 . Acute pulmonary embolism 12 . Pheochromocytoma 13 . Take MAO lnhibitor ( except MAOB ) 14 . Hypotension ( SBP 90mmHg less ) 15 . Severe hepatic dysfunction 16 . Peripheral circulatory disturbance ( ex . Raynaud syndrome , intermittent claudication ) 17 . Has edema glottitis 18 . Has heart attack complication 19 . Fluid retention overload require intravenous inotropes 20 . Allergic rhinitis</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Carvedilol SR Cap</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>Chronic stable angina</keyword>
	<keyword>Congestive heart failure</keyword>
</DOC>